MODIFIED ENDONUCLEASES AND RELATED METHODS
    12.
    发明公开

    公开(公告)号:US20230203462A1

    公开(公告)日:2023-06-29

    申请号:US17767426

    申请日:2020-10-09

    CPC classification number: C12N9/22 C12N15/52 C12N15/113

    Abstract: Provided are compositions and methods for the production of modified endonucleases such as CRISPR/Cas9 system with reduced off-target activity. Methods of editing of polynucleotides using the modified endonucleases in vitro and in vivo are also disclosed. In one aspect, the disclosure provides a modified endonuclease, comprising an endonuclease and one or more mixed charge moieties covalently linked to the endonuclease, wherein each mixed charge moiety comprises about 10 to about 400 positively charged moieties and about 10 to about 400 negatively charged moieties, and wherein the ratio of the number of positively charged moieties to the number of negatively charged moieties is from about 1 :0.5 to about 1 :2.

    PHOTONIC BLOOD TYPING
    20.
    发明申请

    公开(公告)号:US20210088535A1

    公开(公告)日:2021-03-25

    申请号:US17035130

    申请日:2020-09-28

    Abstract: Photonic devices, systems, and methods for detecting an analyte in a biological solution (e.g., whole blood) are provided. Representative photonic devices are optical ring resonators having nanoscale features and micron-sized diameters. Due to the compact size of these devices, many resonators can be disposed on a single substrate and tested simultaneously as a sample is passed over the devices. Typical analytes include blood cells, antibodies, and pathogens, as well as compounds indicative of the presence of blood cells or pathogens (e.g., serology). In certain embodiments, blood type can be determined through photonic sensing using a combination of direct detection of blood cells and serology. By combining the detection signals of multiple devices, the type of blood can be determined.

Patent Agency Ranking